Comments on: Novartis defends Zolgensma in face of FDA’s data concerns

Comments on: Novartis defends Zolgensma in face of FDA’s data concerns /news/fda-novartis-zolgensma-data-concerns/ The leading site for news and procurement in the pharmaceutical industry Wed, 07 Aug 2019 10:20:57 +0000 hourly 1 https://wordpress.org/?v=6.6.2